Carotid atherosclerotic alterations in systemic lupus erythematosus patients treated at a Brazilian university setting

被引:26
作者
Telles, R. W. [1 ]
Lanna, C. C. D. [1 ]
Ferreira, G. A. [1 ]
Souza, A. J.
Navarro, T. P. [2 ]
Ribeiro, A. L. [3 ]
机构
[1] Univ Fed Minas Gerais, Sch Med, Hosp Clin, Rheumatol Serv,Locomotor Syst Dept, Belo Horizonte, MG, Brazil
[2] Univ Fed Minas Gerais, Hosp Clin, Vasc Surg Serv, Belo Horizonte, MG, Brazil
[3] Univ Fed Minas Gerais, Sch Med, Dept Internal Med, Hosp Clin,Cardiol Serv, Belo Horizonte, MG, Brazil
关键词
atherosclerosis; atherosclerotic plaque; carotid ultrasonography; systemic lupus erythematosus; traditional risk factors for coronary artery disease;
D O I
10.1177/0961203307085312
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
To determine the frequency of carotid plaque and intima-media thickness (IMT) in patients with systemic lupus erythematosus (SLE) and their association with risk factors in a Brazilian university setting. Carotid plaque and IMT were identified and measured by ultrasonography. Traditional risk factors and lupus-related factors were analysed. One hundred and seventy-two patients (women = 96%, age = 38 +/- 11 years) were evaluated. The frequency of carotid plaque was 9.3%. The median (IR) IMT was 0.60mm (0.54-0.71 mm). Age, family history (FH) of premature coronary disease, low-density cholesterol (LDL-c) >100 mg/dL, hypertriglyceridemia, diabetes, hypertension, smoking, postmenopause, number of risk factors, Framingham risk score, age at diagnosis, duration of lupus, mucocutaneous manifestations and duration of prednisone use were associated with plaque (P < 0.05), univariate analysis. Nephritis, immunosuppressive therapy, intravenous methylprednisolone and a higher average daily dose of prednisone were associated with the absence of plaque. Independent predictors of plaque were smoking (P = 0.004), LDL-c >100mg/dL (P = 0.044), Framingham score (P = 0.006) and absence of immunosuppressive therapy (P = 0.032). There was an independent correlation between IMT and age (P < 0.001) and duration of prednisone use (P = 0.020). Subclinical atherosclerosis was associated with traditional risk and SLE-related factors, especially the absence of immunosuppressive therapy. The present study suggests that the levels of LDL-c should be kept under 100 mg/dL in lupus.
引用
收藏
页码:105 / 113
页数:9
相关论文
共 53 条
[1]  
American Diabetes Association, 2004, Diabetes Care, V27 Suppl 1, pS5, DOI 10.2337/diacare.27.2007.S5
[2]  
[Anonymous], 2006, Programme d'attribution des terres du domaine de l'etat p our l'implantation d 'eoliennes-Decret 928-2005 . Guide d'information
[3]  
Barr SG, 1999, ARTHRITIS RHEUM, V42, P2682, DOI 10.1002/1529-0131(199912)42:12<2682::AID-ANR26>3.0.CO
[4]  
2-6
[5]   Mortality in systemic lupus erythematosus [J].
Bernatsky, S. ;
Boivin, J. -F. ;
Joseph, L. ;
Manzi, S. ;
Ginzler, E. ;
Gladman, D. D. ;
Urowitz, M. ;
Fortin, P. R. ;
Petri, M. ;
Barr, S. ;
Gordon, C. ;
Bae, S. -C. ;
Isenberg, D. ;
Zoma, A. ;
Aranow, C. ;
Dooley, M. -A. ;
Nived, O. ;
Sturfelt, G. ;
Steinsson, K. ;
Alarcon, G. ;
Senecal, J. -L. ;
Zummer, M. ;
Hanly, J. ;
Ensworth, S. ;
Pope, J. ;
Edworthy, S. ;
Rahman, A. ;
Sibley, J. ;
El-Gabalawy, H. ;
McCarthy, T. ;
Pierre, Y. St. ;
Clarke, A. ;
Ramsey-Goldman, R. .
ARTHRITIS AND RHEUMATISM, 2006, 54 (08) :2550-2557
[6]   Risk of coronary heart disease and stroke in a large British cohort of patients with systemic lupus erythematosus [J].
Bessant, R ;
Hingorani, A ;
Patel, L ;
MacGregor, A ;
Isenberg, DA ;
Rahman, A .
RHEUMATOLOGY, 2004, 43 (07) :924-929
[7]   Measurement error [J].
Bland, JM ;
Altman, DG .
BRITISH MEDICAL JOURNAL, 1996, 312 (7047) :1654-1654
[8]   STATISTICAL METHODS FOR ASSESSING AGREEMENT BETWEEN TWO METHODS OF CLINICAL MEASUREMENT [J].
BLAND, JM ;
ALTMAN, DG .
LANCET, 1986, 1 (8476) :307-310
[9]   Common carotid intima-media thickness and risk of stroke and myocardial infarction - The Rotterdam Study [J].
Bots, ML ;
Hoes, AW ;
Koudstaal, PJ ;
Hofman, A ;
Grobbee, DE .
CIRCULATION, 1997, 96 (05) :1432-1437
[10]   Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) [J].
Cleeman, JI ;
Grundy, SM ;
Becker, D ;
Clark, LT ;
Cooper, RS ;
Denke, MA ;
Howard, WJ ;
Hunninghake, DB ;
Illingworth, DR ;
Luepker, RV ;
McBride, P ;
McKenney, JM ;
Pasternak, RC ;
Stone, NJ ;
Van Horn, L ;
Brewer, HB ;
Ernst, ND ;
Gordon, D ;
Levy, D ;
Rifkind, B ;
Rossouw, JE ;
Savage, P ;
Haffner, SM ;
Orloff, DG ;
Proschan, MA ;
Schwartz, JS ;
Sempos, CT ;
Shero, ST ;
Murray, EZ .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (19) :2486-2497